Clearstream

ClearStream Technologies is a medical device company specializing in the development and manufacture of minimally invasive interventional products for the vascular system. Based in Enniscorthy, Ireland, the company's portfolio includes high-pressure angioplasty catheters, stents, and drug-coated balloons designed to treat peripheral and coronary artery diseases. ClearStream was acquired by C.R. Bard in 2011 for approximately $68 million and subsequently became part of Becton Dickinson (BD) following BD's acquisition of Bard in 2017. The company operates as a critical manufacturing and R&D hub within BD's Peripheral Intervention business unit. Its products, such as the Aperto drug-coated balloon, are utilized globally by interventional cardiologists and radiologists to improve patient outcomes in vascular procedures.